Recent Business Highlights
Second Quarter 2014 Highlights
Total prescriptions for Zohydro ER were 10,299 for the second quarter; 4,076 for the first four weeks of July, up 74% compared to the first four weeks of April; and 1,088 for the most recent week ended July 25 1
Total net revenue of $9.2 million
Zohydro ER net revenue of $2.4 million on prescription demand
Zohydro ER gross factory sales to wholesalers of $4.8 million during the second quarter; $11.6 million year-to-date
SAN DIEGO, Aug.
Excluding significant items, first quarter diluted earnings per share of
$0.20 driven by significant increases in Canadian and US investment
banking revenues (1)
(All dollar amounts are stated in Canadian dollars unless otherwise
indicated) TORONTO , Aug.
Paycom Software, Inc. (“Paycom”) (NYSE:PAYC), a leading provider of a
comprehensive cloud-based human capital management software solution,
today announced its financial results for the quarter ended June 30,
Colony Financial, Inc. (NYSE: CLNY) (the “Company”) today announced
financial results for the second quarter ended June 30, 2014 and
declares a dividend of $0.36 per share of common stock for the third
quarter of 2014.
GAMCO Investors, Inc. (NYSE:GBL) announced today that its Board of
Directors approved a quarterly dividend of $0.06 per share to all of its
Class A and Class B shareholders, payable on September 30, 2014 to its
Class A and Class B shareholders of record on September 16, 2014.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.